Three distinct tolerogenic CD14(+) myeloid cell types to actively manage autoimmune disease: Opportunities and challenges
SourceJournal of Autoimmunity, 120, (2021), article 102645
Article / Letter to editor
Display more detailsDisplay less details
Journal of Autoimmunity
SubjectAll institutes and research themes of the Radboud University Medical Center; Radboudumc 2: Cancer development and immune defence RIMLS: Radboud Institute for Molecular Life Sciences
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.